Financials
- Fiscal year
- 2024
- Total assets
- €629,347
- Profit
- €29,250
- Solvency
- 86.8%
Total assets▼ 6.8%
Net result
20192024
MEDI-MB
ActiveSummary
MEDI-MB has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €545,988 and a net result of €29,250. Equity is shrinking by ~3.7% per year across the filed fiscal years. Its solvency ranks better than 81% of 636 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Activity
Other research and development on natural sciences
NACE 72109NACE 72190NACE 85120
1 site
Size
€629,347total assets 2024
- Staff
- 2 FTE
- Equity
- €545,988
- Profit
- €29,250
Turnover not published (abridged schema)
Structure
Accounts 64 d overdue0 of 2 deeds read
Why 92- Figures for FY 2024 (filed 02-09-2025)+ Liquidity: current ratio 21.08, cash €111,257+ Founded in 2003+ Equity €545,988 (86.8% of total assets)Show the evidence
Checked score
Score 2024
92
/ 100
Excellent
Probability in this band: under 0.55%
Better than 62% of its sector peers (NACE 72, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2023
Strong
Solvency
100=
equity 86.8% of total assets
Liquidity
72-13
short-term debt 4.3% · cash 17.7%
Profitability
75-3
return on assets 4.6%
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: < 0.1%
12-2024: < 0.1%● 0.0% vs 11-2024
01-2025: < 0.1%▼ -2.0% vs 12-2024lowest value
02-2025: < 0.1%▲ +2.1% vs 01-2025
03-2025: < 0.1%● 0.0% vs 02-2025
04-2025: < 0.1%● 0.0% vs 03-2025
05-2025: < 0.1%● 0.0% vs 04-2025
06-2025: 0.1%▲ +6.1% vs 05-2025
07-2025: 0.1%▲ +11.5% vs 06-2025
08-2025: 0.1%▲ +65.5% vs 07-2025
09-2025: 0.1%▲ +1.0% vs 08-2025
10-2025: < 0.1%▼ -48.5% vs 09-2025
11-2025: < 0.1%● 0.0% vs 10-2025
12-2025: < 0.1%● 0.0% vs 11-2025
01-2026: < 0.1%▼ -2.0% vs 12-2025
02-2026: < 0.1%● 0.0% vs 01-2026
03-2026: < 0.1%▲ +2.0% vs 02-2026
04-2026: < 0.1%▼ -2.0% vs 03-2026
05-2026: < 0.1%▲ +2.0% vs 04-2026
06-2026: < 0.1%● 0.0% vs 05-2026
07-2026: 0.1%▲ +4.0% vs 06-2026
08-2026: 0.1%▲ +90.4% vs 07-2026
09-2026: 0.1%▲ +10.1% vs 08-2026
10-2026: 0.2%▲ +43.1% vs 09-2026highest value
- Figures for FY 2024 (filed 02-09-2025) raises the probability
- Liquidity: current ratio 21.08, cash €111,257 lowers the probability
- Founded in 2003 lowers the probability for this profile
- Equity €545,988 (86.8% of total assets) lowers the probability
Credit up to €50,000 at 30 days acceptable
Liquidity ample (current ratio 21.08 against 4.93 in 2023; short-term debt: 4.3% and cash: 17.7% of total assets), and 13.2% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 72, micro). Better than this share of them on solvency 83%, liquidity 60%, profitability 50%, growth against the median 56%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-08-2025, 29 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
29 d late
2023
49 d late
2022
28 d late
2021
21 d late
2020
40 d late
2019
2 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 28 days after the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (1)
- Annual accounts filedfiscal year 2024 · micro…
- Liquidity quadruplescurrent ratio 21.08
- Annual accounts filedfiscal year 2023 · micro…
Key points
By topic
Timeline
- Events
- 12
- Since
- 2016
- 29-08-2025Annual accounts filed
- 31-12-2024Liquidity quadruples
- 18-09-2024Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Other research and development on natural sciencesNACE 72109
- Founded
- 10-07-2003
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.